Retention Disorders, Cognitive Clinical Trial
Official title:
Efficacy and Tolerance of EGb 761® 120mg Two Times a Day on Dementia of Alzheimer Type's Onset in Patients Suffering From Memory Complaints. A Randomised, Double-blind, Multicentre, Parallel Groups, Placebo Controlled Phase IIIb/IV Study in Elderly Over 70
The purpose of this study is to determine whether Tanakan® is effective at slowing the progression from memory complaint to dementia of Alzheimer's type.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02007564 -
Legacy Intervention Family Enactment (LIFE)
|
N/A | |
Completed |
NCT02005679 -
Mini-Mental State (MMS-LS) and Sign Language
|
N/A |